Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyMaarten J. Titulaer, Josep Dalmau, Lindsey McCracken et al.|The Lancet Neurology|2013Cited by 3.1k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisJosep Dalmau, Rita J. Balice‐Gordon, Eric Lancaster et al.|The Lancet Neurology|2010Cited by 2.4k
Investigations of caspr2, an autoantigen of encephalitis and neuromyotoniaEric Lancaster, Josep Dalmau, Maartje G. Huijbers et al.|Annals of Neurology|2010Cited by 728
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysisThaís Armangué, Clàudia Fortuny, Marianna Spatola et al.|The Lancet Neurology|2018Cited by 645
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodiesMar Petit‐Pedrol, Josep Dalmau, Thaís Armangué et al.|The Lancet Neurology|2014Cited by 615